Sunil Singhal News Today

Biotechnology company Vergent Bioscience has revealed that VGT-309, its investigational tumor-targeted fluorescent imaging agent, is able to help surgeons see lung tumors in real time during surgical procedures.

Tata Steel Jamshedpur, Meramandali, Kalinganagar receives Value Engineering awards from INVEST | Corporate News | The Avenue Mail

/PRNewswire/ -- ResearchAndMarkets.com proudly announces the addition of the "Next-Gen Digital Pathology Conference" to its extensive list of offerings, set to...

 · The two labs demonstrate the commitment of IIT Roorkee and the Department of Hydro and Renewable Energy to meet India's Energy Independence and Net Zero Carbon Energy Systems Goals.ROORKEE: Prof. K.K. Pant, Director, IIT Roorkee, inaugurated

These labs were developed to ensure IIT Roorkee remains at the forefront of India's clean energy transition, focusing on a reliable, resilient, and

More than 130,000 Americans die of lung cancer each year, making lung cancer the leading cause of cancer mortality in the country. Lung cancer mortality is high largely because it tends to be...

The U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery.

The FDA approved the imaging agent Cytalux for use in lung cancer cases to help surgeons find and remove previously unidentified tumors.

The U.S. Food and Drug Administration (FDA) has approved the targeted imaging agent Cytalux (pafolacianine) for use in lung cancer surgery. This injectable diagnostic binds to cancerous tissue and...

/PRNewswire/ -- On Target Laboratories, Inc., a privately-held biotechnology company developing intraoperative molecular imaging agents to target and...